Outcome of Board Meeting dated 15th October 2025.

Revenue Growth 20pctEbitda Margin CompressionNegative Operating CashflowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.8%Reaction day

₹96.50

prior close

₹96.45

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+4.3% vs market

Trading - Chemicals peers, median of 12sector-0.4%+5.2% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 5.2 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

+0.0

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.8+0.5+4.3-0.4+5.2

Next day

+7.6+0.0+7.6-0.6+8.2

+7.3+1.0+6.2+0.6+6.6

+5.2+2.1+3.1+0.2+5.0

+6.7+1.6+5.2-0.3+7.1

+7.5+1.2+6.2-0.9+8.3

+7.7+1.9+5.8-2.9+10.6

15d

+8.3+0.4+7.9-2.1+10.4

-3.7+1.5-5.2-2.5-1.2

-8.8-4.4-4.4-12.8+4.0

-34.7-7.2-27.5-18.4-16.4

UpDownMarket · Nifty Microcap 250Sector · Trading - Chemicals peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Yash Chemex's board approved its Q2 and H1 FY26 (ended 30 Sept 2025) un-audited financial results on 15 October 2025. Standalone revenue from operations surged to Rs. 2,255.96 lakhs in Q2 (up ~45% YoY from Rs. 1,553.40 lakhs) and Rs. 4,030.59 lakhs for H1 (up ~72% YoY). Consolidated revenue from operations grew to Rs. 3,864.75 lakhs in Q2 (~58% YoY) and Rs. 6,875.21 lakhs in H1 (~81% YoY), driven by subsidiary Yasons Chemex Care Limited. However, profitability lagged: standalone net profit was Rs. 46.19 lakhs in Q2 (down ~11% YoY) and Rs. 75.85 lakhs in H1 (flat YoY), while consolidated net profit declined to Rs. 91.37 lakhs in Q2 and Rs. 177.17 lakhs in H1 (down ~24% YoY), reflecting margin compression from rising input and operating costs. The statutory auditor S. L. Patel & Co. issued an unmodified (clean) limited review opinion on both sets of results.

Likely market impact

Strong top-line growth is a positive, but shrinking bottom-line and significant margin compression signal rising cost pressures that investors should watch. The negative consolidated operating cash flow of Rs. 106.36 lakhs in H1 indicates working-capital strain despite higher sales, which may temper near-term optimism.